首页> 外文会议>Bioengineering and Translational Medicine Conference >A New Pulmonary Drug Targeted Delivery Method for Lung Diseases Treatment: An in Silico Study
【24h】

A New Pulmonary Drug Targeted Delivery Method for Lung Diseases Treatment: An in Silico Study

机译:一种新的肺部药物靶向肺疾病治疗方法:在硅研究中

获取原文

摘要

Pulmonary drug delivery therapies,ranging from the treatment of asthma and chronic obstructive pulmonary diseases(COPD)to lung tumors and systemic diseases,have gained considerable interest in recent years.Advantages of pulmonary drug delivery,when compared with conventional medical treatments include improvements in efficiency because of the large surface area of the lung and the thin epithelial layer thickness,reduction of systemic drug levels with a decrease in adverse effects,and higher degree of convenience.
机译:肺药递送疗法,从治疗哮喘和慢性阻塞性肺病(COPD)到肺肿瘤和全身疾病,近年来都获得了相当大的兴趣。与常规医学治疗相比,肺药递送的态度包括提高效率由于肺的大表面积和薄的上皮层厚度,减少了系统性药物水平,减少了不利影响,方便更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号